Показано 0 из 0
Дата |
---|
11:00 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.93
|
0.965
|
0.915
|
0.915
|
0.915
|
0.915
|
|
|
|
|
0.925
|
0.955
|
0.94
|
0.94
|
0.94
|
0.94
|
|
|
|
|
0.955
|
0.99
|
0.955
|
0.945
|
0.955
|
0.945
|
|
|
|
|
0.93
|
0.96
|
0.91
|
0.905
|
0.91
|
0.905
|
|
|
|
|
0.925
|
0.955
|
0.955
|
0.935
|
0.955
|
0.935
|
|
|
|
|
0.93
|
0.96
|
0.955
|
0.955
|
0.955
|
0.955
|
|
|
|
|
0.94
|
0.975
|
0.97
|
0.96
|
0.97
|
0.96
|
|
|
|
|
0.955
|
0.99
|
0.955
|
0.955
|
0.985
|
0.985
|
|
|
|
|
0.95
|
0.985
|
0.925
|
0.92
|
0.935
|
0.935
|
|
|
|
|
0.92
|
0.955
|
0.95
|
0.945
|
0.955
|
0.945
|
|
|
|
|
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.